JNJ
Healthcare
J&J Sales Rose 5.9% But A Talc Charge Cut GAAP EPS To $0.09 Against $2.59 Adjusted
J&J's Q3 2026 sales rose 5.9% with the US up 9.1% and international 1.5%, but a talc charge cut GAAP EPS to $0.09 against $2.59 adjusted while full-year adjusted EPS guidance rose to $11.10.